Mechanism of the nuclear receptor molecular switch

Trends in Biochemical Sciences

Volumn 29, Issue 6, 2004, Pages 317-324

  Nagy, Laszlo ^a   Schwabe, John W R ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOIC ACID RECEPTOR; THYROID HORMONE RECEPTOR; VITAMIN D RECEPTOR;

ALPHA HELIX; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; LIGAND BINDING; MOLECULAR INTERACTION; POLARIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; LIGANDS; MOLECULAR STRUCTURE; PROTEIN CONFORMATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 3242784885     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2004.04.006     Document Type: Review

References (70)

1. Kushiro T., et al. Hormone evolution: the key to signalling. Nature. 422:2003;122
2. Toft D., et al. A receptor molecule for estrogens: studies using a cell-free system. Proc. Natl. Acad. Sci. U. S. A. 57:1967;1740-1743
3. Jensen E.V., DeSombre E.R. Mechanism of action of the female sex hormones. Annu. Rev. Biochem. 41:1972;203-230
4. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895
5. Robinson-Rechavi M., et al. The nuclear receptor superfamily. J. Cell Sci. 116:2003;585-586
6. Owen G.I., Zelent A. Origins and evolutionary diversification of the nuclear receptor superfamily. Cell. Mol. Life Sci. 57:2000;809-827
7. Mangelsdorf D.J., Evans R.M. The RXR heterodimers and orphan receptors. Cell. 83:1995;841-850
8. Chawla A., et al. Nuclear receptors and lipid physiology: opening the X-files. Science. 294:2001;1866-1870
9. Dupe V., et al. In vivo functional analysis of the Hoxa-1 3′ retinoic acid response element (3′RARE). Development. 124:1997;399-410
10. Mark M., et al. A genetic dissection of the retinoid signalling pathway in the mouse. Proc. Nutr. Soc. 58:1999;609-613
11. Lin R.J., et al. Molecular genetics of acute promyelocytic leukemia. Trends Genet. 15:1999;179-184
12. Shao W., Brown M. Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy. Breast Cancer Res. 6:2004;39-52
13. Laue L., et al. Receptor-mediated effects of glucocorticoids on inflammation: enhancement of the inflammatory response with a glucocorticoid antagonist. J. Steroid Biochem. 29:1988;591-598
14. Kersten S., et al. Roles of PPARs in health and disease. Nature. 405:2000;421-424
15. Renaud J.P., Moras D. Structural studies on nuclear receptors. Cell. Mol. Life Sci. 57:2000;1748-1769
16. Wurtz J.-M., et al. A canonical structure for the ligand-binding domain of nuclear receptors. Nat. Struct. Biol. 3:1996;87-94
17. Bourguet W., et al. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α Nature. 375:1995;377-382
18. Wagner R.L., et al. A structural role for hormone in the thyroid hormone receptor. Nature. 378:1995;690-697
19. Brzozowski A.M., et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature. 389:1997;753-758
20. Nolte R.T., et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ Nature. 395:1998;137-143
21. Uppenberg J., et al. Crystal structure of the ligand binding domain of the human nuclear receptor PPARγ J. Biol. Chem. 273:1998;31108-31112
22. Watkins R.E., et al. The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science. 292:2001;2329-2333
23. Watkins R.E., et al. Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor. J. Mol. Biol. 331:2003;815-828
24. Clayton G.M., et al. The structure of the ultraspiracle ligand-binding domain reveals a nuclear receptor locked in an inactive conformation. Proc. Natl. Acad. Sci. U. S. A. 98:2001;1549-1554
25. Billas I.M., et al. Crystal structure of the ligand-binding domain of the ultraspiracle protein USP, the ortholog of retinoid X receptors in insects. J. Biol. Chem. 276:2001;7465-7474
26. Wang Z., et al. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature. 423:2003;555-560
27. Baker K.D., et al. The Drosophila orphan nuclear receptor DHR38 mediates an atypical ecdysteroid signaling pathway. Cell. 113:2003;731-742
28. Renaud J.P., et al. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature. 378:1995;681-689
29. Gampe R.T. Jr, et al. Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix. Genes Dev. 14:2000;2229-2241
30. Sablin E.P., et al. Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1. Mol. Cell. 11:2003;1575-1585
31. McKenna N.J., et al. Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20:1999;321-344
32. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:2000;121-141
33. Chen J.D., Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature. 377:1995;454-457
34. Horlein A.J., et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature. 377:1995;397-404
35. Sande S., Privalsky M.L. Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. Mol. Endocrinol. 10:1996;813-825
36. Onate S.A., et al. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science. 270:1995;1354-1357
37. Chakravarti D., et al. Role of CBP/P300 in nuclear receptor signalling. Nature. 383:1996;99-103
38. Ogryzko V.V., et al. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 87:1996;953-959
39. Chen H., et al. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell. 90:1997;569-580
40. Heery D.M., et al. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 387:1997;733-736
41. Darimont B.D., et al. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12:1998;3343-3356
42. Hu X., Lazar M.A. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature. 402:1999;93-96
43. Nagy L., et al. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev. 13:1999;3209-3216
44. Perissi V., et al. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev. 13:1999;3198-3208
45. Webb P., et al. The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs). Mol. Endocrinol. 14:2000;1976-1985
46. Marimuthu A., et al. TR surfaces and conformations required to bind nuclear receptor corepressor. Mol. Endocrinol. 16:2002;271-286
47. Benko S., et al. Molecular determinants of the balance between co-repressor and co-activator recruitment to the retinoic acid receptor. J. Biol. Chem. 278:2003;43797-43806
48. Shiau A.K., et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell. 95:1998;927-937
49. Xu H.E., et al. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARα Nature. 415:2002;813-817
50. Leng X., et al. Ligand-dependent conformational changes in thyroid hormone and retinoic acid receptors are potentially enhanced by heterodimerization with retinoic X receptor. J. Steroid Biochem. Mol. Biol. 46:1993;643-661
51. Keidel S., et al. Different agonist- and antagonist-induced conformational changes in retinoic acid receptors analyzed by protease mapping. Mol. Cell. Biol. 14:1994;287-298
52. Pissios P., et al. Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding. Mol. Cell. 6:2000;245-253
53. Johnson B.A., et al. Ligand-induced stabilization of PPARγ monitored by NMR spectroscopy: implications for nuclear receptor activation. J. Mol. Biol. 298:2000;187-194
54. Cronet P., et al. Structure of the PPARα and -γ ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family. Structure. 9:2001;699-706
55. Gee A.C., Katzenellenbogen J.A. Probing conformational changes in the estrogen receptor: evidence for a partially unfolded intermediate facilitating ligand binding and release. Mol. Endocrinol. 15:2001;421-428
56. Kallenberger B.C., et al. A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease. Nat. Struct. Biol. 10:2003;136-140
57. Tamrazi A., et al. Molecular sensors of estrogen receptor conformations and dynamics. Mol. Endocrinol. 17:2003;2593-2602
58. Germain P., et al. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature. 415:2002;187-192
59. Stehlin-Gaon C., et al. All-trans retinoic acid is a ligand for the orphan nuclear receptor RORβ Nat. Struct. Biol. 10:2003;820-825
60. Forman B.M., et al. Androstane metabolites bind to and deactivate the nuclear receptor CAR-β Nature. 395:1998;612-615
61. Nettles K.W., et al. Allosteric control of ligand selectivity between estrogen receptors α and β: implications for other nuclear receptors. Mol. Cell. 13:2004;317-327
62. Metivier R., et al. Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell. 115:2003;751-763
63. Pike A.C., et al. Structure of the ligand-binding domain of oestrogen receptor β in the presence of a partial agonist and a full antagonist. EMBO J. 18:1999;4608-4618
64. Black B.E., et al. DNA binding domains in diverse nuclear receptors function as nuclear export signals. Curr. Biol. 11:2001;1749-1758
65. Gronemeyer H., Moras D. Nuclear receptors. How to finger DNA. Nature. 375:1995;190-191
66. Schwabe J.W., Rhodes D. Beyond zinc fingers: steroid hormone receptors have a novel structural motif for DNA recognition. Trends Biochem. Sci. 16:1991;291-296
67. Khorasanizadeh S., Rastinejad F. Nuclear-receptor interactions on DNA-response elements. Trends Biochem. Sci. 26:2001;384-390
68. Schwabe J.W., Teichmann S.A. Nuclear receptors: the evolution of diversity. Sci. STKE. 2004:2004;PE4
69. Moore L.B., et al. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J. Biol. Chem. 275:2000;15122-15127
70. Svensson S., et al. Crystal structure of the heterodimeric complex of LXRα and RXRβ ligand-binding domains in a fully agonistic conformation. EMBO J. 22:2003;4625-4633